Your Article Summary
See Latest ArticlesRetrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier
Annals of Oncology, 06/29/09
Fukushima N et al. - Rituximab plus steroid-containing regimens may increase the risk of HBV reactivation in HBsAg-negative and HBcAb-positive lymphoma patients. More ambitious prospective studies are required to establish clinically useful or cost-effective follow-up methods for control of HBV reactivation in lymphoma patients with occult HBV infection.
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin
Journal of Viral Hepatitis, 11/09/09
Silent Epidemic of Viral Hepatitis May Lead to Boom in Serious Liver Disease
JAMA, 11/12/09
Optimizing the treatment of chronic viral hepatitis C
Expert Review of Gastroenterology & Hepatology, 11/30/09